Lily Chang

Lily joins Novo Holdings in 2024, and brings experience in medical technology start-up operations, and commercial and vendor due diligence. 

Prior to joining Novo Holdings, she was an investor at HealthQuest Capital and Kaiser Permanente ventures. She diligenced and supported companies across life sciences, medtech, healthcare services, and healthcare IT. 

Her professional journey began at LEK Consulting where she provided strategic advice to healthcare clients and conducted acquisition diligence. Following this, she joined the digital health start-up HeartFlow, where she was instrumental in managing and developing the commercialization and expansion strategy and operations for their businesses in the US, UK, and Europe.

Lily holds a BS in Industrial Engineering and Management Sciences from Northwestern University.